These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1242 related items for PubMed ID: 30138892

  • 1. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
    Fu L, Zhu P, Qi S, Li C, Zhao K.
    Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M, Liu B, He H, Gu Z, Liu Y, Su Y, Zhu D, Cang J, Luo Z.
    Cell Cycle; 2018 Nov; 17(16):2001-2018. PubMed ID: 30231673
    [Abstract] [Full Text] [Related]

  • 3. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
    Huang Y, Huang L, Zhu G, Pei Z, Zhang W.
    J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway.
    Wang T, Jiang L, Wei X, Dong Z, Liu B, Zhao J, Wang L, Xie P, Wang Y, Zhou S.
    Cell Cycle; 2019 Aug; 18(16):1893-1907. PubMed ID: 31208297
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of miR-let-7e attenuates LPS-induced acute lung injury in mice via inhibiting pulmonary inflammation by targeting SCOS1/NF-κB pathway.
    Li W, Zhang W, Liu J, Han Y, Jiang H, Ji G, Liu W.
    Biosci Rep; 2021 Jan 29; 41(1):. PubMed ID: 33392621
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-326 aggravates acute lung injury in septic shock by mediating the NF-κB signaling pathway.
    Wu CT, Huang Y, Pei ZY, Xi X, Zhu GF.
    Int J Biochem Cell Biol; 2018 Aug 29; 101():1-11. PubMed ID: 29727715
    [Abstract] [Full Text] [Related]

  • 7. Suppressed nuclear factor-kappa B alleviates lipopolysaccharide-induced acute lung injury through downregulation of CXCR4 mediated by microRNA-194.
    Chen R, Xie F, Zhao J, Yue B.
    Respir Res; 2020 Jun 10; 21(1):144. PubMed ID: 32522221
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of microRNA-92a ameliorates lipopolysaccharide-induced endothelial barrier dysfunction by targeting ITGA5 through the PI3K/Akt signaling pathway in human pulmonary microvascular endothelial cells.
    Xu F, Zhou F.
    Int Immunopharmacol; 2020 Jan 10; 78():106060. PubMed ID: 31841757
    [Abstract] [Full Text] [Related]

  • 9. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-κB signaling pathways.
    Yu X, Yu S, Chen L, Liu H, Zhang J, Ge H, Zhang Y, Yu B, Kou J.
    Biomed Pharmacother; 2016 Aug 10; 82():489-97. PubMed ID: 27470389
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 10; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 11. The Functional Mechanisms of miR-30b-5p in Acute Lung Injury in Children.
    Zhou T, Chen YL.
    Med Sci Monit; 2019 Jan 02; 25():40-51. PubMed ID: 30600796
    [Abstract] [Full Text] [Related]

  • 12. MiR-142a-3p alleviates Escherichia coli derived lipopolysaccharide-induced acute lung injury by targeting TAB2.
    Yang Y, Yang C, Guo YF, Liu P, Guo S, Yang J, Zahoor A, Shaukat A, Deng G.
    Microb Pathog; 2019 Nov 02; 136():103721. PubMed ID: 31494298
    [Abstract] [Full Text] [Related]

  • 13. microRNAs mediate oleic acid-induced acute lung injury in rats using an alternative injury mechanism.
    Lee SM, Choi H, Yang G, Park KC, Jeong S, Hong S.
    Mol Med Rep; 2014 Jul 02; 10(1):292-300. PubMed ID: 24736893
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA‑17 contributes to the suppression of the inflammatory response in lipopolysaccharide‑induced acute lung injury in mice via targeting the toll‑like receptor 4/nuclear factor‑κB pathway.
    Fu S.
    Int J Mol Med; 2020 Jul 02; 46(1):131-140. PubMed ID: 32626914
    [Abstract] [Full Text] [Related]

  • 15. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.
    Lin Y, Yang Y.
    Pathol Res Pract; 2019 Apr 02; 215(4):683-688. PubMed ID: 30600184
    [Abstract] [Full Text] [Related]

  • 16. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X, Sun CY, Zhang YB, Guo HZ, Feng XX, Peng SZ, Yuan J, Zheng RB, Chen WP, Su ZR, Huang XD.
    J Ethnopharmacol; 2016 Jun 20; 186():91-102. PubMed ID: 27036629
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA‑93 contributes to the suppression of lung inflammatory responses in LPS‑induced acute lung injury in mice via the TLR4/MyD88/NF‑κB signaling pathway.
    Gao H, Xiao D, Gao L, Li X.
    Int J Mol Med; 2020 Aug 20; 46(2):561-570. PubMed ID: 32468034
    [Abstract] [Full Text] [Related]

  • 18. miRNA-206-3p alleviates LPS-induced acute lung injury via inhibiting inflammation and pyroptosis through modulating TLR4/NF-κB/NLRP3 pathway.
    Chen M, Zhang J, Huang H, Wang Z, Gao Y, Liu J.
    Sci Rep; 2024 May 24; 14(1):11860. PubMed ID: 38789583
    [Abstract] [Full Text] [Related]

  • 19. 4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models.
    Zeng M, Sang W, Chen S, Chen R, Zhang H, Xue F, Li Z, Liu Y, Gong Y, Zhang H, Kong X.
    Toxicol Lett; 2017 Apr 05; 271():26-37. PubMed ID: 28245985
    [Abstract] [Full Text] [Related]

  • 20. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W, Qiu X, Jiang H, Zhi Y, Fu J, Liu J.
    Int Immunopharmacol; 2015 Dec 05; 29(2):560-567. PubMed ID: 26481965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.